Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Hemispherx Biopharma Inc (NYSE American:HEB)

0.33
Delayed Data
As of Dec 11
 -0.0325 / -8.97%
Today’s Change
0.30
Today|||52-Week Range
0.93
-52.16%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 4
2016
Quarter 1
2017
Quarter 2
2017
Quarter 3
2017
Revenue and IncomeNet Revenues16.0K84.0K213.0K90.0K
 
 
 
 
 
Cost of Goods Sold116.0K133.0K94.5K133.0K
 
 
 
 
 
Depreciation And Amortization324.0K274.0K247.0K266.0K
 
 
 
 
 
 
Operating ExpensesGross Income-424.0K-323.0K-128.5K-309.0K
 
 
 
 
 
General Expenses3.7M2.9M2.6M2.3M
 
 
 
 
 
Research And Development1.9M1.4M1.1M787.0K
 
 
 
 
 
Total Operating Expenses4.1M3.3M2.9M2.7M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-4.1M-3.2M-2.7M-2.7M
 
 
 
 
 
Extraordinary Credit1.6M393.0K529.0K1.4M
 
 
 
 
 
Interest Expense On Debt0.000.0019.0K51.0K
 
 
 
Other Expenses1.3M1.0K6.0K0.00
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-1.2M-2.8M-2.2M-1.3M
 
 
 
 
 
Net Income-1.2M-2.8M-2.2M-1.3M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS24.2M25.3M27.3M30.1M
 
 
 
 
 
Shares To Calculate EPS Diluted24.2M25.3M27.3M30.1M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.04-$0.11-$0.08-$0.04
 
 
 
 
 
EPS Diluted-$0.05-$0.11-$0.08-$0.04